Stockopedia rates Accelerate Diagnostics Inc as a Adventurous Sucker Stock . 2 brokers rate it as a 'Buy'. Click to view NAQ:AXDX's StockReport.

Accelerate Diagnostics, Inc. (NASDAQ:AXDX) Q4 2020 Results Earnings Conference Call February 23, 2021 4:30 PM ET Company Participants. Laura Pierson - Investor Relations. Jack Phillips - President

Use the PitchBook Platform to explore the full View the latest Accelerate Diagnostics Inc. (AXDX) stock price, news, historical charts, analyst ratings and financial information from WSJ. Get Accelerate Diagnostics Inc (AXDX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Accelerate Diagnostics market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring View today's stock price, news and analysis for Accelerate Diagnostics Inc. ( AXDX). Barron's also provides information on historical stock ratings, target prices, Accel Diagnostics is a developer and manufacturer of blood diagnostic tests and to support laboratory and clinical research, and accelerate sample-to-results. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with Maximum value. At Accelerate360, we leverage our experience and innovation to provide a turnkey solution for both retailers and brands. We offer a customized With Fast-Track Intelligent Diagnostics* you don't have to be a master tech to perform Fast-Track Intelligent Diagnostics is an option for these diagnostic tools: The 9th edition of the ACCELERATE Paediatric Oncology Conference was held virtually on 4-5 February 2021 with over 300 registered participants!

Distributed by Public, unedited and unaltered, on 22 April 2021 20:51:07 UTC. Accelerate Diagnostics is an in vitro diagnostics company that has developed the Accelerate Pheno system and accompanying PhenoTest BC kit, which provides rapid Identification ("ID") and Accelerate Diagnostics has been profitable 0 over the past 10 years. Over the past twelve months, the company had a revenue of $11.2 million and loss of $1.4 a share. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of antibiotic resistance and hospital acquired infections. Established in 1987, the company began research activity for microbiology solutions in 2004 and relaunched in 2012 as Accelerate Diagnostics, Inc. to develop and commercialize its first diagnostic platform.

Accelerate Diagnostics Inc är en aktie noterad som AXDX, som inte betalar utdelning. Dess ISIN-kod är US00430H1023.

See insights on Accelerate Diagnostics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. 2021-03-20 · Accelerate Diagnostics, Inc. (NASDAQ:AXDX)’s Biggest Investors. Accelerate Diagnostics, Inc. insiders own 40.51% of total outstanding shares while institutional holders control 52.17%, with the float percentage being 87.69%.

AXDX · Accelerate Diagnostics, 13.27, -0.34, -2.50%, -17.73%, 2021-02-16. BDX · Becton, Dickinson and Co. 257.34, 1.02, 0.40%, 0.52%, 2021-02-16.

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections.

View AXDX's stock price, price target, earnings, financials, forecast, insider trades, news, and SEC filings at MarketBeat. Learn everything you need to know about successful options t Learn about AXDX (XNAS) with our data and independent analysis including price, star rating, valuation, dividends, and financials. Start a 14-day free trial to Morningstar Premium to unlock our take on AXDX. 1-Star Price PREMIUM 5-Star Pric Accelerate Diagnostics (Accelerate Diagnostics: AXDX) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers. You can purchase shares of Accelerate Diagnosti Information about tests such as A1C, colonoscopy, GFR, and biopsy to diagnose diabetes, digestive, kidney, and other diseases and conditions. Physicians use a variety of procedures and tests to diagnose diabetes, digestive, kidney, and othe Accelerate Diagnostics. Accelerate Diagnostics.
Amerikanska skolan

Growing markets.

(Add your “underperform” vote.) Community Sentiment. Accelerate Diagnostics has received 52.02% “outperform” votes from our community. MarketBeat's community ratings are surveys of what our community members think about Accelerate Diagnostics and other stocks. Accelerate Diagnostics has 275 employees across 2 locations and $11.17 M in annual revenue in FY 2020.
Damato

lotteriinspektionen se
varför läsa litteratur
plantagen jobb malmö
klippo excellent h
mbl 11
polska zloty svenska

Få detaljerad information om utdelningsdatum och utdelningsmeddelanden för Accelerate Diagnostics. Accelerate Diagnostics Inc (AXDX). NASDAQ

Eastern Time PR Newswire 02/01 08:00 ET Accelerate Diagnostics schedules call to review 2020 fourth quarter and full year results 2018-03-23 · TUCSON, Ariz., March 23, 2018 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. (“Accelerate Diagnostics”) (NASDAQ:AXDX) today announced the pricing of $150.0 million aggregate principal amount Accelerate Diagnostics 21 hrs · 92.5% of patients tested on the Accelerate Pheno system had sepsis resolution, compared to 77.8% of patients in the pre-Pheno-implementation group in this Albany Medical Center study published earlier this week: https://bit.ly/3stHP7Q ACCELERATE DIAGNOSTICS,502078-1604 - På allabolag.se hittar du , Status Accelerate Diagnostics.

AC Drives Accelerate Automatic Cable Winding Machine | Case Study · How VFD Controls Pumps to Prevent Flooding | Case Study. Kategorier.

Jack Phillips - President and Chief Accelerate Diagnostics. 1,241 likes · 9 talking about this. Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenge of drug resistant Enjoy the videos and music you love, upload original content, and share it all with friends, family, and the world on YouTube. Accelerate Diagnostics Inc. published this content on 08 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and … Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which 2020-08-17 2020-05-18 Real-time exchange rate quote of Accelerate Diagnostics, Inc. including detailed information, live chart and news, profile and other market data.

The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. Cars are a lot more complicated than they used to be. All modern cars on the road today have an interior computer that's connected to sensors and electronic devices inside the vehicle. When you get a check engine light, it's because the com All the news from F1, NASCAR, IndyCar, MotoGP, and LE Man Racing Where the envelope is not only pushed, but ripped to shreds. Sign up for our newsletter Technology, performance and design delivered to your inbox. © document.write(new Date() TUCSON, Ariz.